NEW YORK (GenomeWeb) - Interleukin Genetics yesterday reported after the close of the market a 59 percent decrease in third quarter revenues.

For the three months ended Sept. 30, the Waltham, Massachusetts-based genetic testing firm tallied total revenues of $295,998, compared to $472,151 in the prior-year period.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A federal grand jury has indicted Elizabeth Holmes and Ramesh Balwani for alleged wire fraud in conjunction with their activities at Theranos.

Nature News reports that some developers are nervous about GitHub's acquisition by Microsoft.

A direct-to-consumer genetic testing company sent out used spit kits, CNBC reports.

In PLOS this week: comparison of commercial bisulfite kits, new method to predict essential proteins, and more